US Stock MarketDetailed Quotes

BridgeBio Pharma (BBIO)

Watchlist
  • 76.260
  • -1.640-2.11%
Close Jan 15 15:59 ET
  • 76.260
  • 0.0000.00%
Post 20:01 ET
14.70BMarket Cap-18.11P/E (TTM)

BridgeBio Pharma (BBIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
4,318.01%120.7M
4,999.86%110.57M
-44.76%116.63M
2,285.27%221.9M
237.08%5.88M
-33.22%2.73M
32.11%2.17M
11,461.88%211.12M
-88.02%9.3M
-6.68%1.75M
Operating revenue
4,318.01%120.7M
4,999.86%110.57M
-44.76%116.63M
2,285.27%221.9M
237.08%5.88M
-33.22%2.73M
32.11%2.17M
11,461.88%211.12M
-88.02%9.3M
-6.68%1.75M
Cost of revenue
997.49%6.56M
510.87%3.65M
341.30%2.64M
58.54%3.88M
248.49%2.08M
0.00%598K
-0.17%598K
-8.14%598K
-28.77%2.45M
-7.57%598K
Gross profit
5,248.50%114.14M
6,709.68%106.91M
-45.85%113.99M
3,079.58%218.02M
231.12%3.8M
-38.91%2.13M
50.67%1.57M
17,816.77%210.52M
-90.76%6.86M
-6.21%1.15M
Operating expense
32.35%250.5M
37.98%240.39M
5.33%217.8M
31.19%795.39M
26.61%225.13M
17.62%189.26M
21.31%174.22M
66.80%206.78M
11.73%606.3M
44.84%177.81M
Selling and administrative expenses
99.98%137.62M
116.98%129.15M
61.63%106.37M
91.87%288.93M
99.19%94.78M
92.36%68.82M
64.78%59.52M
111.54%65.81M
5.17%150.59M
49.34%47.58M
Research and development costs
-6.29%112.87M
-3.02%111.23M
-20.96%111.43M
11.14%506.46M
0.10%130.35M
-3.75%120.44M
6.70%114.7M
51.81%140.97M
14.08%455.71M
43.26%130.23M
Operating profit
27.13%-136.36M
22.69%-133.47M
-2,873.23%-103.8M
3.68%-577.37M
-25.29%-221.33M
-18.87%-187.13M
-21.10%-172.65M
103.05%3.74M
-27.97%-599.44M
-45.35%-176.66M
Net non-operating interest income expense
-112.04%-41.91M
-90.16%-33.74M
-89.50%-36.76M
-29.71%-82.04M
-71.12%-25.14M
-19.69%-19.77M
-10.34%-17.74M
-21.47%-19.4M
13.23%-63.25M
7.60%-14.69M
Non-operating interest income
89.29%6.24M
-24.97%3.9M
32.15%5.39M
-4.37%17.25M
-16.05%4.68M
-13.10%3.3M
15.09%5.2M
-1.88%4.08M
139.17%18.04M
36.31%5.58M
Non-operating interest expense
108.79%48.15M
64.09%37.64M
79.54%42.14M
22.14%99.29M
47.13%29.82M
13.57%23.06M
11.38%22.94M
16.65%23.47M
1.06%81.29M
1.39%20.27M
Other net income (expense)
-119.26%-8.21M
-112.58%-14.45M
-41.66%-29.05M
1,141.16%117.22M
-194.01%-19.76M
867.60%42.64M
5,688.61%114.85M
-416.55%-20.51M
-83.34%9.44M
771.48%21.02M
Gain on sale of security
----
--7M
----
-55.57%8.14M
----
----
----
----
322.74%18.31M
----
Earnings from equity interest
-141.26%-15.83M
-154.75%-20.19M
---15.56M
---31.18M
---16.7M
---6.56M
---7.93M
--0
--0
--0
Special income (charges)
-84.51%7.62M
-100.66%-805K
27.56%-21.73M
1,591.63%136.13M
-725.14%-15.34M
985.74%49.2M
3,576.95%122.77M
-790.18%-29.99M
79.15%-9.13M
-43.83%2.45M
-Less:Restructuring and merger&acquisition
91.32%8.84M
-72.15%805K
-81.78%570K
93.46%15.33M
522.41%4.69M
1,598.90%4.62M
-18.13%2.89M
-7.12%3.13M
-74.47%7.93M
-90.20%754K
-Less:Impairment of capital assets
--0
--0
--0
--271K
--0
--0
--0
--271K
--0
--0
-Less:Other special charges
----
----
-20.44%21.16M
--26.59M
--0
----
----
--26.59M
----
----
-Gain on sale of business
--0
--0
----
14,960.08%178.32M
--0
--52.03M
--126.29M
----
---1.2M
---1.2M
-Gain on sale of property,plant,equipment
816.03%16.46M
1,136.08%6.55M
----
----
----
134.01%1.8M
---632K
----
----
----
Other non- operating income (expenses)
----
-196.58%-452K
-13.20%8.23M
1,515.63%4.14M
----
----
515.79%468K
1,677.87%9.48M
-99.76%256K
----
Income before tax
-13.53%-186.48M
-140.47%-181.66M
-369.05%-169.61M
17.00%-542.19M
-56.31%-266.24M
8.49%-164.25M
52.99%-75.54M
74.67%-36.16M
-34.79%-653.25M
-21.17%-170.33M
Income tax
-1.55M
2.1M
1.15M
1.15M
0
0
0
Net income
-12.59%-184.94M
-143.25%-183.76M
-369.05%-169.61M
16.82%-543.35M
-56.98%-267.39M
8.49%-164.25M
52.99%-75.54M
74.67%-36.16M
-34.79%-653.25M
-21.17%-170.33M
Net income continuous Operations
-12.59%-184.94M
-143.25%-183.76M
-369.05%-169.61M
16.82%-543.35M
-56.98%-267.39M
8.49%-164.25M
52.99%-75.54M
74.67%-36.16M
-34.79%-653.25M
-21.17%-170.33M
Minority interest income
0.90%-2.19M
11.16%-1.86M
-131.57%-2.19M
24.52%-7.59M
-7.29%-2.34M
11.05%-2.21M
25.53%-2.09M
63.35%-944K
-189.68%-10.05M
26.82%-2.18M
Net income attributable to the parent company
-12.78%-182.74M
-147.64%-181.9M
-375.41%-167.42M
16.70%-535.76M
-57.63%-265.05M
8.45%-162.04M
53.48%-73.46M
74.87%-35.22M
-33.67%-643.2M
-22.21%-168.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-12.78%-182.74M
-147.64%-181.9M
-375.41%-167.42M
16.70%-535.76M
-57.63%-265.05M
8.45%-162.04M
53.48%-73.46M
74.87%-35.22M
-33.67%-643.2M
-22.21%-168.15M
Basic earnings per share
-10.47%-0.95
-143.59%-0.95
-340.00%-0.88
27.09%-2.88
-45.83%-1.4
20.37%-0.86
60.20%-0.39
78.26%-0.2
-21.17%-3.95
-4.35%-0.96
Diluted earnings per share
-10.47%-0.95
-143.59%-0.95
-340.00%-0.88
27.09%-2.88
-45.83%-1.4
20.37%-0.86
60.20%-0.39
78.26%-0.2
-21.17%-3.95
-4.35%-0.96
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 4,318.01%120.7M4,999.86%110.57M-44.76%116.63M2,285.27%221.9M237.08%5.88M-33.22%2.73M32.11%2.17M11,461.88%211.12M-88.02%9.3M-6.68%1.75M
Operating revenue 4,318.01%120.7M4,999.86%110.57M-44.76%116.63M2,285.27%221.9M237.08%5.88M-33.22%2.73M32.11%2.17M11,461.88%211.12M-88.02%9.3M-6.68%1.75M
Cost of revenue 997.49%6.56M510.87%3.65M341.30%2.64M58.54%3.88M248.49%2.08M0.00%598K-0.17%598K-8.14%598K-28.77%2.45M-7.57%598K
Gross profit 5,248.50%114.14M6,709.68%106.91M-45.85%113.99M3,079.58%218.02M231.12%3.8M-38.91%2.13M50.67%1.57M17,816.77%210.52M-90.76%6.86M-6.21%1.15M
Operating expense 32.35%250.5M37.98%240.39M5.33%217.8M31.19%795.39M26.61%225.13M17.62%189.26M21.31%174.22M66.80%206.78M11.73%606.3M44.84%177.81M
Selling and administrative expenses 99.98%137.62M116.98%129.15M61.63%106.37M91.87%288.93M99.19%94.78M92.36%68.82M64.78%59.52M111.54%65.81M5.17%150.59M49.34%47.58M
Research and development costs -6.29%112.87M-3.02%111.23M-20.96%111.43M11.14%506.46M0.10%130.35M-3.75%120.44M6.70%114.7M51.81%140.97M14.08%455.71M43.26%130.23M
Operating profit 27.13%-136.36M22.69%-133.47M-2,873.23%-103.8M3.68%-577.37M-25.29%-221.33M-18.87%-187.13M-21.10%-172.65M103.05%3.74M-27.97%-599.44M-45.35%-176.66M
Net non-operating interest income expense -112.04%-41.91M-90.16%-33.74M-89.50%-36.76M-29.71%-82.04M-71.12%-25.14M-19.69%-19.77M-10.34%-17.74M-21.47%-19.4M13.23%-63.25M7.60%-14.69M
Non-operating interest income 89.29%6.24M-24.97%3.9M32.15%5.39M-4.37%17.25M-16.05%4.68M-13.10%3.3M15.09%5.2M-1.88%4.08M139.17%18.04M36.31%5.58M
Non-operating interest expense 108.79%48.15M64.09%37.64M79.54%42.14M22.14%99.29M47.13%29.82M13.57%23.06M11.38%22.94M16.65%23.47M1.06%81.29M1.39%20.27M
Other net income (expense) -119.26%-8.21M-112.58%-14.45M-41.66%-29.05M1,141.16%117.22M-194.01%-19.76M867.60%42.64M5,688.61%114.85M-416.55%-20.51M-83.34%9.44M771.48%21.02M
Gain on sale of security ------7M-----55.57%8.14M----------------322.74%18.31M----
Earnings from equity interest -141.26%-15.83M-154.75%-20.19M---15.56M---31.18M---16.7M---6.56M---7.93M--0--0--0
Special income (charges) -84.51%7.62M-100.66%-805K27.56%-21.73M1,591.63%136.13M-725.14%-15.34M985.74%49.2M3,576.95%122.77M-790.18%-29.99M79.15%-9.13M-43.83%2.45M
-Less:Restructuring and merger&acquisition 91.32%8.84M-72.15%805K-81.78%570K93.46%15.33M522.41%4.69M1,598.90%4.62M-18.13%2.89M-7.12%3.13M-74.47%7.93M-90.20%754K
-Less:Impairment of capital assets --0--0--0--271K--0--0--0--271K--0--0
-Less:Other special charges ---------20.44%21.16M--26.59M--0----------26.59M--------
-Gain on sale of business --0--0----14,960.08%178.32M--0--52.03M--126.29M-------1.2M---1.2M
-Gain on sale of property,plant,equipment 816.03%16.46M1,136.08%6.55M------------134.01%1.8M---632K------------
Other non- operating income (expenses) -----196.58%-452K-13.20%8.23M1,515.63%4.14M--------515.79%468K1,677.87%9.48M-99.76%256K----
Income before tax -13.53%-186.48M-140.47%-181.66M-369.05%-169.61M17.00%-542.19M-56.31%-266.24M8.49%-164.25M52.99%-75.54M74.67%-36.16M-34.79%-653.25M-21.17%-170.33M
Income tax -1.55M2.1M1.15M1.15M000
Net income -12.59%-184.94M-143.25%-183.76M-369.05%-169.61M16.82%-543.35M-56.98%-267.39M8.49%-164.25M52.99%-75.54M74.67%-36.16M-34.79%-653.25M-21.17%-170.33M
Net income continuous Operations -12.59%-184.94M-143.25%-183.76M-369.05%-169.61M16.82%-543.35M-56.98%-267.39M8.49%-164.25M52.99%-75.54M74.67%-36.16M-34.79%-653.25M-21.17%-170.33M
Minority interest income 0.90%-2.19M11.16%-1.86M-131.57%-2.19M24.52%-7.59M-7.29%-2.34M11.05%-2.21M25.53%-2.09M63.35%-944K-189.68%-10.05M26.82%-2.18M
Net income attributable to the parent company -12.78%-182.74M-147.64%-181.9M-375.41%-167.42M16.70%-535.76M-57.63%-265.05M8.45%-162.04M53.48%-73.46M74.87%-35.22M-33.67%-643.2M-22.21%-168.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -12.78%-182.74M-147.64%-181.9M-375.41%-167.42M16.70%-535.76M-57.63%-265.05M8.45%-162.04M53.48%-73.46M74.87%-35.22M-33.67%-643.2M-22.21%-168.15M
Basic earnings per share -10.47%-0.95-143.59%-0.95-340.00%-0.8827.09%-2.88-45.83%-1.420.37%-0.8660.20%-0.3978.26%-0.2-21.17%-3.95-4.35%-0.96
Diluted earnings per share -10.47%-0.95-143.59%-0.95-340.00%-0.8827.09%-2.88-45.83%-1.420.37%-0.8660.20%-0.3978.26%-0.2-21.17%-3.95-4.35%-0.96
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More